# 334 - Cardiovascular disease, the number one killer: development, biomarkers, apoB, and more

**Channel:** Peter Attia MD
**Upload Date:** 2025-02-03
**URL:** https://www.youtube.com/watch?v=5hiLY5oFprY
**Duration:** 144 minutes

## Description

Tom Dayspring is a world-renowned expert in clinical lipidology & a previous guest on The Drive. In this episode, Tom explores the foundations of atherosclerosis & why atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide for both men & women. He examines how the disease develops from a pathological perspective & discusses key risk factors, including often-overlooked contributors such as insulin resistance & chronic kidney disease. He breaks down the complexities of cholesterol & lipoproteins with an in-depth discussion on the critical role of apolipoprotein B (apoB) in the development of atherosclerosis. He covers the importance of testing various biomarkers, the impact of nutrition on lipid levels, & the vital role of cholesterol in brain health, including how cholesterol is synthesized & managed in the brain, how it differs from cholesterol regulation in the rest of the body, & how pharmacological interventions can influence brain cholesterol metabolism.

View show notes here: https://bit.ly/3WFZURi
Become a member to receive exclusive content: https://peterattiamd.com/subscribe/
Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/

We discuss:
0:00:00-Intro
0:01:07-Defining atherosclerotic cardiovascular disease (ASCVD)
0:09:52-The pathogenesis of ASCVD: the silent development over decades
0:16:52-Risk factors versus risk markers, & how insulin resistance & chronic kidney disease contribute to atherosclerosis
0:24:19-How hyperinsulinemia elevates cardiovascular risk
0:30:30-How apoB-containing lipoproteins contribute to atherosclerosis, & why measuring apoB is the superior indicator of cardiovascular risk
0:48:08-Challenges of detecting early-stage atherosclerosis before calcification appears
0:57:50-Lp(a): structure, genetic basis, & significant risks associated with elevated Lp(a)
1:02:30-How aging & lifestyle factors contribute to rising apoB & LDL cholesterol levels, & the lifestyle changes that can lower it
1:11:32-How elevated triglycerides, driven by insulin resistance, increase apoB particle concentration & promote atherosclerosis
1:25:59-How LDL particle size, remnant lipoproteins, Lp(a), & non-HDL cholesterol contribute to cardiovascular risk beyond apoB levels
1:33:25-Limitations of using HDL cholesterol as a marker for heart health
1:41:35-Critical role of cholesterol in brain function & how the brain manages its cholesterol supply
1:51:40-Impact of ApoE genotype on brain health & Alzheimer's disease risk
1:56:18-How the brain manages cholesterol through specialized pathways, & biomarkers to track cholesterol health of the brain
2:03:43-How statins might affect brain cholesterol synthesis & cognitive function, & alternative lipid-lowering strategies for high-risk individuals
2:16:20-Exciting advancements in therapeutics, diagnostics, & biomarkers coming in the next few years
2:19:33-Recent consensus statements on apoB & Lp(a) from the National Lipid Association (NLA)

--------
About:

The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, and all that goes into that from physical to cognitive to emotional health. With over 90 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimerâ€™s disease, cancer, mental health, and much more.

Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan. 

Learn more: https://peterattiamd.com

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle

Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit my website where I keep an up-to-date and active list of such companies. For a full list of our registered and unregistered trademarks, trade names, and service marks, please review our Terms of Use: https://peterattiamd.com/terms-of-use/

## AI Summary

Here's my comprehensive analysis of this episode of The Drive podcast:

1. **Executive Summary**:
This episode focused on atherosclerotic cardiovascular disease (ASCVD), featuring Dr. Tom Dayspring. The discussion covered the pathophysiology of atherosclerosis, the role of apoB and lipoproteins, and brain cholesterol metabolism. Key themes included the importance of apoB as a primary risk marker, the relationship between triglycerides and cardiovascular disease, and the complex role of cholesterol in brain health.

2. **Key Medical/Scientific Points**:
- ASCVD is the leading cause of death globally [00:00:00]
- Atherosclerosis begins in childhood and takes decades to develop [00:14:00]
- ApoB is considered the primary marker for cardiovascular risk [00:27:00]
- Brain cholesterol is synthesized locally, not transported from peripheral circulation [01:45:50]
- Cholesterol half-life in the brain is approximately 5 years [01:46:48]

3. **Health Optimization Tips**:

Universal recommendations:
- Monitor apoB and triglycerides as primary markers [01:17:25]
- Consider getting LP(a) tested once in lifetime [02:20:04]

Context-specific recommendations:
- Lower triglycerides and saturated fat intake to reduce apoB [01:09:26]
- Use low-dose statins when possible [02:14:59]

4. **Supplements & Medications**:

Medications mentioned:
- Statins (various types) [02:12:57]
- PCSK9 inhibitors
- Bempedoic acid
- Ezetimibe

5. **Biomarkers & Testing**:
- ApoB as primary marker [01:17:25]
- Triglycerides
- LP(a)
- Desmosterol (for brain cholesterol synthesis) [02:01:10]
- Calcium score for atherosclerosis detection

6. **Notable Quotes**:
"Cholesterol is almost certainly the most important molecule in the brain" [01:45:50]

7. **Follow-up Questions**:
- What is the optimal timing for first apoB testing in young adults?
- How do different dietary patterns affect brain cholesterol synthesis?
- What role does inflammation play in early atherosclerosis development?

Would you like me to expand on any particular section or provide more specific details from other categories?
